Monday, 09 Dec 2019

You are here

RheumNow Podcast – The End of Arthritis (9.13.19)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.

  1. TICOPA study was a T2T strategy trial in psoriatic arthritis to improve outcomes. 5 yr outcomes of 110 pts shows simlar low Dz activity in TC 69% vs SOC 76%. Biologic use was higher in TC ( 33%). Not much advantage to TC - just more biologics and less MTX https://buff.ly/2I2Mus8   
  2. UK Clinical Practice Database compared 68,897 gout pts vs 554,964 without gout, showing gout doubles risk of (8.5/1000PY vs 4.1/1000PY w/o gout). Risk highest with ESRD. Gout did not increase CKD related deaths. https://t.co/oHpxa3ybVK
  3. Based on a literature review, the prevalence of AA Amyloidosis in Adult onset Still's dz was 0.88%. 16 pt review showed mean age at AOSD onset was 30 yrs & a mean delay before AAA diagnosis of 16.75 yrs. Renal involvement was most common AAA feature. https://t.co/ur02T7d0EA
  4. A changing spectrum of Hydralazine induced lupus? Several reports showing cases of the usual (pleuropericarditis, arthriti + Skin, +ANA) but also the unusual (ANA neg, ANCA/PR3/MPO positive, Bx proven nephritis and +ACL, +dsDNA) https://t.co/WgOZ4NdrUS https://t.co/eQYWzFfq3F
  5. VA study of RA pts (2002-12) shows persistence on Rx at 1 year was 45% in for MTX- TNFi (n = 2,125) and 18% for triple therapy (MSH) (n = 171) (P < 0.001). Triple therapy group was associated with signicantly more treatment discontinuation (from SSZ) 
  6. FDA Approves Ofev (nintedanib) for Interstitial Lung Disease Associated with Systemic Sclerosis or Scleroderma (SSc-ILD) https://t.co/nTrENZmaqR PI: https://t.co/1kZygrH8E7
  7. Two vs. Four Weeks of Antibiotic Therapy in Septic  Arthritis  
  8. Bimekizumab Add-on Therapy in Rheumatoid Arthritis  
  9. Need for Pre-operative Hyperglycemia Testing Prior to Total Joint Replacement 

Add new comment

More Like This

RheumNow Podcast - Monitoring Methotrexate Safety (12-6-19)

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.

#WomenInRheumatology: Is There a Speaker Gender Gap at ACR Meetings?

Recent studies have quantified the gender gap among speakers at academic conferences. The largest study of 181 medical conferences held in North America over one decade found an increase in the proportion of female speakers from 25 to 34% over time, and that the underrepresentation of women was more marked at surgical compared to medical conferences.

RheumNow Podcast –Favorites of ACR 2019 (11.22.19)

Dr. Jack Cush recaps standout presentations and information from ACR 2019 held in Atlanta November 9-12, 2019.

Hepatitis C-Related Cryoglobulinemic Vasculitis

Flares of vasculitis can still be a problem after hepatitis C-related cryoglobulinemic vasculitis patients are cured of their hepatitis C by direct-acting antivirals, as demonstrated by data from four registries presented at ACR 2019 in Atlanta, Georgia.

ACR 2019 - Report from Day One (Sunday)

Sunday was the first full day of scientific sessions at the 2019 ACR/ARP meeting in Atlanta. Yesterday we shared our initial news articles, videos and more with you. Following is my roundup of day one. 

Delays in Diagnosis